|

Pegylated SN-38 Conjugate PLX038 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PLX 038, PLX-038, PLX038, Pegylated SN-38 PLX038

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Platinum-Resistant Primary Peritoneal Carcinoma1
  • Platinum-Resistant Fallopian Tube Carcinoma1
  • Platinum-Resistant Ovarian Carcinoma1
  • Stage IV Primary Peritoneal Cancer AJCC v81
  • Stage IV Ovarian Cancer AJCC v81

Rochester, Minnesota1 trial

PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Mayo Clinic

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.